FDA Establishes Public Docket for Comments on Best Practices for Drug Safety Surveillance

Summary

The FDA is seeking public comment on a draft document outlining best practices for postmarket safety surveillance of drug and biological products, as mandated by the 21st Century Cures Act, which requires the agency to make such practices publicly available.